Company Profile
PharmaBlock Sciences (Nanjing) provides chemistry products and services throughout the pharmaceutical research and development, and commercial manufacturing in China and globally.
It offers medicinal chemistry-oriented SAR/SPR tool kits for molecule design. Its portfolio also includes building blocks enabled libraries, including fragment-based drug discovery, and mega virtual library screening to support the discovery of novel hit compounds, custom synthesis (FFS), and full time equivalent (FTE)
Small molecule drug substance CDMO services, including optimal route scouting. Its portfolio also includes FFS and FTE for process R&D of RSMs, intermediates, and APIs, impurity studies and synthesis, solid state chemistry, analytical development and quality control, cGMP manufacturing of intermediates and APIs, and CMC regulatory filing support.
Additionally, it offers small molecule DP CDMO services, such as candidate screening and selection, early development, full development, registration, and post-approval; and new modality services
Including target protein degrader, peptide, oligonucleotide, and ADC services. Founded in 2006, PharmaBlock Sciences (Nanjing) is based in Nanjing, the People's Republic of China.